GSK Keeps an Eye on Vaccines Business with Potential ID Biomedical Acquisition
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 64 (Table of Contents)
Published: 1 Oct-2005
DOI: 10.3833/pdr.v2005.i64.613 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Despite being the biggest vaccines deal in history, the announcement of this alliance was met with a largely negative response from ID Biomedical shareholders...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS